The Symrise AG Supervisory Board has extended the contract with Chief Executive Officer Dr. Heinz-Jürgen Bertram until the end of 2017. The contracts with Hans Holger Gliewe, Board Member for the Flavor & Nutrition division, and Chief Financial Officer, Bernd Hirsch, were extended until the end of 2015. This step ensures continuity in Symrise’s senior management team. Achim Daub who is responsible for the Scent & Care division is also part of the Board.
Dr. Thomas Rabe, Chairman of the Supervisory Board, said: “We are delighted about the contract extensions for Dr. Bertram, Mr. Gliewe and Mr. Hirsch. Together with their colleague Achim Daub, they form an experienced and successful management team that will continue to lead the company with a steady hand and clear perspective. This continuity is a very strong signal to staff, customers and shareholders. Symrise is excellently positioned, both strategically and financially, and has best possible prospects for further profitable growth. The Supervisory Board looks forward to continuing the successful working relationship with the Executive Board over the coming years.”
Dr. Heinz-Jürgen Bertram has meanwhile over twenty years’ service at Symrise and its predecessor company, Haarmann & Reimer. Mr. Bertram, who has a PhD in chemistry, was appointed to the Executive Board in 2006 and became Chief Executive Officer in 2009.
Hans Holger Gliewe began his career in 1982 at the former Haarmann & Reimer and held a range of managerial positions for many years in Latin America. He was appointed to the Symrise AG Executive Board on November 1, 2009.
Bernd Hirsch has held the post of Symrise AG Chief Financial Officer since December 1, 2009. Before that, he was Chief Financial Officer of Carl Zeiss Meditec AG.
The contract with the fourth Executive Board member, Achim Daub, runs until the end of 2013 and is thus not yet due for extension.